Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.42 |
| ▸ | CASP3 | P42574 | 2/20 | 0.42 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.40 |
| ▸ | FABP7 | O15540 | 1/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31733654 | 1.00 | KMT2A (0.51) | KMT2AEPHX2OPRD1CASP3FABP5 | |
| SCHEMBL3060297 | 1.00 | KMT2A (0.51) | KMT2AEPHX2OPRD1CASP3FABP5 | |
| SCHEMBL29995975 | 0.95 | KMT2A (0.48) | KMT2AEPHX2OPRD1CASP3FABP5 | |
| SCHEMBL30895521 | 0.95 | KMT2A (0.48) | KMT2AEPHX2OPRD1CASP3FABP5 | |
| SCHEMBL3087950 | 0.88 | KMT2A (0.58) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL29470973 | 0.84 | KMT2A (0.57) | KMT2AEPHX2OPRD1CASP3FABP5 | |
| SCHEMBL12391727 | 0.84 | KMT2A (0.57) | KMT2AEPHX2OPRD1CASP3FABP5 | |
| SCHEMBL7855942 | 0.84 | KMT2A (0.69) | KMT2AEPHX2CASP3 | |
| SCHEMBL17015150 | 0.84 | KMT2A (0.57) | KMT2AEPHX2OPRD1CASP3FABP5 | |
| SCHEMBL30174112 | 0.83 | KMT2A (0.59) | KMT2AEPHX2OPRD1CASP3FABP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120058835-A | Preparation method of Fmoc-Gly-Ser { Psi (Me, me) Pro } -OH pseudo dipeptide | 苏州正济医药研究有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-119019488-A | Preparation method of chiral Fmoc-Gly-L-Pro-OH dipeptide | 苏州正济医药研究有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-120058835-A | Preparation method of Fmoc-Gly-Ser { Psi (Me, me) Pro } -OH pseudo dipeptide | 苏州正济医药研究有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-120058835-A | Preparation method of Fmoc-Gly-Ser { Psi (Me, me) Pro } -OH pseudo dipeptide | 苏州正济医药研究有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119019488-A | Preparation method of chiral Fmoc-Gly-L-Pro-OH dipeptide | 苏州正济医药研究有限公司 | 2024-11-26 | — | — | CN | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| CN-113403358-B | Synthesis method and application of ALG1-CDG and PMM2-CDG biomarkers | 江南大学 | 2023-11-17 | — | — | CN | disclosed |
| US-20230357763-A1 | Morpholinos with Increased Delivery Efficiency | MORPHOLINO THERAPEUTICS LLC | 2023-11-09 | — | — | US | disclosed |
| CN-116829949-A | Compositions for detecting or measuring analytes | 伯蒂斯有限公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |